WO2000015665A3 - Procede de production d'une proteine fonctionnelle de la superfamille des immunoglobulines - Google Patents
Procede de production d'une proteine fonctionnelle de la superfamille des immunoglobulines Download PDFInfo
- Publication number
- WO2000015665A3 WO2000015665A3 PCT/DK1999/000484 DK9900484W WO0015665A3 WO 2000015665 A3 WO2000015665 A3 WO 2000015665A3 DK 9900484 W DK9900484 W DK 9900484W WO 0015665 A3 WO0015665 A3 WO 0015665A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein
- functional
- immunoglobulin superfamily
- class
- mhc class
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020017003306A KR20010075108A (ko) | 1998-09-14 | 1999-09-14 | 기능적 면역글로불린 수퍼패밀리 단백질을 생산하는 방법 |
NZ511031A NZ511031A (en) | 1998-09-14 | 1999-09-14 | A method of producing a functional immunoglobulin superfamily protein |
EP99941420A EP1114063A2 (fr) | 1998-09-14 | 1999-09-14 | Procede de production d'une proteine fonctionnelle de la superfamille des immunoglobulines |
MXPA01002674A MXPA01002674A (es) | 1998-09-14 | 1999-09-14 | Un metodo para producir una proteina de la superfamilia de inmunoglobulina funcional. |
BR9914491-3A BR9914491A (pt) | 1998-09-14 | 1999-09-14 | Processo para produção de uma proteìna de superfamìlia de imunoglobulina funcional |
JP2000570203A JP2002524104A (ja) | 1998-09-14 | 1999-09-14 | 機能化免疫グロブリンスーパーファミリータンパク質を製造する方法 |
AU55047/99A AU771239C (en) | 1998-09-14 | 1999-09-14 | A method of producing a functional immunoglobulin superfamily protein |
CA002343313A CA2343313A1 (fr) | 1998-09-14 | 1999-09-14 | Procede de production d'une proteine fonctionnelle de la superfamille des immunoglobulines |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199801155 | 1998-09-14 | ||
DKPA199801155 | 1998-09-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000015665A2 WO2000015665A2 (fr) | 2000-03-23 |
WO2000015665A3 true WO2000015665A3 (fr) | 2000-08-17 |
Family
ID=8101632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DK1999/000484 WO2000015665A2 (fr) | 1998-09-14 | 1999-09-14 | Procede de production d'une proteine fonctionnelle de la superfamille des immunoglobulines |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1114063A2 (fr) |
JP (1) | JP2002524104A (fr) |
KR (1) | KR20010075108A (fr) |
CN (1) | CN1326466A (fr) |
AU (1) | AU771239C (fr) |
BR (1) | BR9914491A (fr) |
CA (1) | CA2343313A1 (fr) |
MX (1) | MXPA01002674A (fr) |
NZ (1) | NZ511031A (fr) |
WO (1) | WO2000015665A2 (fr) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8969042B2 (en) | 2004-08-19 | 2015-03-03 | Biogen Idec Ma Inc. | Refolding transforming growth factor beta family proteins |
US9138461B2 (en) | 2007-05-01 | 2015-09-22 | Biogen Ma Inc. | Compositions and methods for increasing vascularization |
US9404916B2 (en) | 2008-09-20 | 2016-08-02 | University College Cardiff Consultants Limited | Use of a protein kinase inhibitor to detect immune cells, such as T cells |
US11992518B2 (en) | 2008-10-02 | 2024-05-28 | Agilent Technologies, Inc. | Molecular vaccines for infectious disease |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1377609B1 (fr) | 2001-03-14 | 2015-06-24 | Dako Denmark A/S | Nouvelles constructions de molecules mhc, methodes d'utilisation de ces constructions a des fins de diagnostic et de therapie et utilisations de molecules mhc |
AU2003223936A1 (en) * | 2002-05-17 | 2003-12-02 | Kobenhavns Universitet | Method for purifying denatured proteins having a desired disulfide bond configuration |
US20040072262A1 (en) | 2002-10-11 | 2004-04-15 | Montero-Julian Felix A. | Methods and systems for detecting MHC class I binding peptides |
WO2004072112A2 (fr) * | 2003-02-11 | 2004-08-26 | Københavns Universitet | Procede de preparation de molecules de type mhc pour stockage prolonge |
EP1706720A4 (fr) * | 2003-10-31 | 2007-02-28 | Vitatex Inc | Prototypes d'analyses sanguines et methodes de detection de cellules tumorales et endotheliales |
US7678379B2 (en) | 2004-06-17 | 2010-03-16 | Beckman Coulter, Inc. | Mycobacterium tuberculosis epitopes and methods of use thereof |
TWI501774B (zh) | 2006-02-27 | 2015-10-01 | Biogen Idec Inc | 神經性病症之治療 |
CL2007002225A1 (es) * | 2006-08-03 | 2008-04-18 | Astrazeneca Ab | Agente de union especifico para un receptor del factor de crecimiento derivado de plaquetas (pdgfr-alfa); molecula de acido nucleico que lo codifica; vector y celula huesped que la comprenden; conjugado que comprende al agente; y uso del agente de un |
WO2008116468A2 (fr) | 2007-03-26 | 2008-10-02 | Dako Denmark A/S | Complexes peptidiques du cmh et leurs utilisations dans des maladies infectieuses |
EP3620465A1 (fr) | 2007-07-03 | 2020-03-11 | Dako Denmark A/S | Procédés améliorés pour produire, marquer et utiliser des multimères du cmh |
KR101643514B1 (ko) * | 2007-07-09 | 2016-07-27 | 제넨테크, 인크. | 폴리펩티드의 재조합 생산 동안의 디술피드 결합 환원의 방지 |
EP2197908A2 (fr) | 2007-09-27 | 2010-06-23 | Dako Denmark A/S | Multimères cmh dans le diagnostic, le vaccin et le traitement de la tuberculose |
GB2453589A (en) | 2007-10-12 | 2009-04-15 | King S College London | Protease inhibition |
DK2254592T3 (da) | 2008-02-28 | 2019-09-09 | Dako Denmark As | MHC-multimerer til Borrelia-diagnostik og sygdom |
WO2010009735A2 (fr) | 2008-07-23 | 2010-01-28 | Dako Denmark A/S | Analyse et réparation combinatoires |
US10369204B2 (en) | 2008-10-02 | 2019-08-06 | Dako Denmark A/S | Molecular vaccines for infectious disease |
CN103364558A (zh) * | 2013-07-17 | 2013-10-23 | 江阴泽成生物技术有限公司 | 一种人肿瘤标志物癌胚抗原(cea)的磁微粒化学发光免疫分析试剂盒及其检测方法 |
CN109402036A (zh) * | 2018-11-07 | 2019-03-01 | 河北科技师范学院 | 牛源肠炎沙门菌trxB基因缺失的应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993022332A2 (fr) * | 1992-04-24 | 1993-11-11 | Board Of Regents, The University Of Texas System | Production recombinante de domaines semblables a l'immunoglobuline dans des cellules procaryotes |
WO1994006813A1 (fr) * | 1992-09-15 | 1994-03-31 | The Rockefeller University | Molecules de systeme majeur d'histocompatibilite et leurs modifications |
WO1995011702A1 (fr) * | 1993-10-25 | 1995-05-04 | Anergen, Inc. | Expression procaryote de proteines du cmh |
US5529921A (en) * | 1992-02-19 | 1996-06-25 | Scripps Research Institute | In vitro activation of cytotoxic t-cells using insect cells expressing human class I MHC and β2-microglobulin |
WO1997044667A2 (fr) * | 1996-05-21 | 1997-11-27 | Institut Pasteur | Methodes d'utilisation de complexes peptide/complexe majeur d'histocompatibilite pour obtenir ou purifier des cellules t antigene-specifiques et pour stimuler des cellules t |
-
1999
- 1999-09-14 NZ NZ511031A patent/NZ511031A/en unknown
- 1999-09-14 AU AU55047/99A patent/AU771239C/en not_active Ceased
- 1999-09-14 CN CN99813211A patent/CN1326466A/zh active Pending
- 1999-09-14 MX MXPA01002674A patent/MXPA01002674A/es unknown
- 1999-09-14 WO PCT/DK1999/000484 patent/WO2000015665A2/fr not_active Application Discontinuation
- 1999-09-14 CA CA002343313A patent/CA2343313A1/fr not_active Abandoned
- 1999-09-14 EP EP99941420A patent/EP1114063A2/fr not_active Withdrawn
- 1999-09-14 JP JP2000570203A patent/JP2002524104A/ja active Pending
- 1999-09-14 KR KR1020017003306A patent/KR20010075108A/ko not_active Application Discontinuation
- 1999-09-14 BR BR9914491-3A patent/BR9914491A/pt not_active IP Right Cessation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5529921A (en) * | 1992-02-19 | 1996-06-25 | Scripps Research Institute | In vitro activation of cytotoxic t-cells using insect cells expressing human class I MHC and β2-microglobulin |
WO1993022332A2 (fr) * | 1992-04-24 | 1993-11-11 | Board Of Regents, The University Of Texas System | Production recombinante de domaines semblables a l'immunoglobuline dans des cellules procaryotes |
WO1994006813A1 (fr) * | 1992-09-15 | 1994-03-31 | The Rockefeller University | Molecules de systeme majeur d'histocompatibilite et leurs modifications |
WO1995011702A1 (fr) * | 1993-10-25 | 1995-05-04 | Anergen, Inc. | Expression procaryote de proteines du cmh |
WO1997044667A2 (fr) * | 1996-05-21 | 1997-11-27 | Institut Pasteur | Methodes d'utilisation de complexes peptide/complexe majeur d'histocompatibilite pour obtenir ou purifier des cellules t antigene-specifiques et pour stimuler des cellules t |
Non-Patent Citations (6)
Title |
---|
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; MOLLOY P E ET AL: "Production of soluble single-chain T-cell receptor fragments in Escherichia coli trxB mutants.", XP002131051, retrieved from STN Database accession no. 1998346783 * |
GARBOCZI D N ET AL: "HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (1992 APR 15) 89 (8) 3429-33., XP002131059 * |
MOLECULAR IMMUNOLOGY, (1998 FEB) 35 (2) 73-81. * |
PARKER K C ET AL: "An HLA-A2/beta 2-microglobulin/peptide complex assembled from subunits expressed separately in Escherichia coli.", MOLECULAR IMMUNOLOGY, (1992 MAR) 29 (3) 371-8., XP000876800 * |
PLAKSIN D ET AL: "A T cell receptor V alpha domain expressed in bacteria: does it dimerize in solution?.", JOURNAL OF EXPERIMENTAL MEDICINE, (1996 OCT 1) 184 (4) 1251-8., XP000876791 * |
STEVENS JAMES ET AL: "Efficient generation of major histocompatibility complex class I-peptide complexes using synthetic peptide libraries.", JOURNAL OF BIOLOGICAL CHEMISTRY JAN. 30, 1998, vol. 273, no. 5, 30 January 1998 (1998-01-30), pages 2874 - 2884, XP002136475, ISSN: 0021-9258 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8969042B2 (en) | 2004-08-19 | 2015-03-03 | Biogen Idec Ma Inc. | Refolding transforming growth factor beta family proteins |
US9138461B2 (en) | 2007-05-01 | 2015-09-22 | Biogen Ma Inc. | Compositions and methods for increasing vascularization |
US9404916B2 (en) | 2008-09-20 | 2016-08-02 | University College Cardiff Consultants Limited | Use of a protein kinase inhibitor to detect immune cells, such as T cells |
US11992518B2 (en) | 2008-10-02 | 2024-05-28 | Agilent Technologies, Inc. | Molecular vaccines for infectious disease |
Also Published As
Publication number | Publication date |
---|---|
NZ511031A (en) | 2003-11-28 |
JP2002524104A (ja) | 2002-08-06 |
KR20010075108A (ko) | 2001-08-09 |
CA2343313A1 (fr) | 2000-03-23 |
AU771239B2 (en) | 2004-03-18 |
MXPA01002674A (es) | 2002-06-04 |
WO2000015665A2 (fr) | 2000-03-23 |
AU5504799A (en) | 2000-04-03 |
CN1326466A (zh) | 2001-12-12 |
BR9914491A (pt) | 2002-01-15 |
AU771239C (en) | 2004-10-14 |
EP1114063A2 (fr) | 2001-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000015665A3 (fr) | Procede de production d'une proteine fonctionnelle de la superfamille des immunoglobulines | |
EP1108724A3 (fr) | Synthèse de methoxy nucléosides et de molécules d'acide nucléique enzymatique | |
WO2003059935A3 (fr) | Methodes de purification d'une proteine | |
AU9125198A (en) | Compositions, kits, and methods for effecting adenine nucleotide modulation of dna mismatch recognition proteins | |
WO2002072605A3 (fr) | Technique d'expression pour des proteines contenant un fragment d'anticorps isotype chimerique | |
WO1999057280A3 (fr) | Compositions et antigenes a base de meningocoque | |
WO1996022308A3 (fr) | Facteur de suppression d'appetit et procedes connexes | |
AU4626596A (en) | Process for preparing macrophages, and kits and compositions therefore | |
EP2330197A3 (fr) | Agents antagonistes de liaison sélective de protéine de liaison d'ostéoprotégérine | |
WO2003020932A1 (fr) | Nouvelles proteines de secretion et adn associe | |
WO2002042424A3 (fr) | Elements regulatoires a expression preferee dans les semences et utilisations de ceux-ci | |
AU2002348563A1 (en) | Nucleic acid enrichment | |
WO1996034107A3 (fr) | Proteines antivirales, sequences d'adn codant pour ces proteines et utilisations | |
EP1304383A3 (fr) | Promoteur du virus bacilliforme de la canne à sucre | |
CA2079454A1 (fr) | Steroide-5.alpha. reductase | |
DE69604240D1 (de) | Polyarylensulfid, Verfahren zu seiner Herstellung und dieses umfassende Masse | |
WO1997043409A3 (fr) | Procede d'obtention de nouvelles sequences d'adn | |
WO1995029236A3 (fr) | Antigenes d'activation de lymphocytes et anticorps correspondants | |
EP0864647B8 (fr) | Oxydase de fructosylaminoacides, son procede d'obtention, et methode d'essai des composes d'amadori utilisant ladite oxydase | |
WO1996027665A3 (fr) | Proteines ayant les proprietes d'un facteur silenceur exerçant une action de repression sur les neurones | |
DE69735264D1 (de) | Gefrierschutzproteine aus choristoneura sp., gene und verfahren zu ihrer verwendung | |
WO2000028014A3 (fr) | Transformation des plastes chez les solanacees | |
EP0270930A3 (fr) | Préparations substantiellement pures de conjugués enzyme-anticorps | |
MX9806041A (es) | Proteina purificada sr-p70. | |
AU3107699A (en) | Novel forms of t cell costimulatory proteins, nucleic acid molecules, and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 99813211.X Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ CZ DE DE DK DK EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ CZ DE DE DK DK EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
ENP | Entry into the national phase |
Ref document number: 2343313 Country of ref document: CA Ref document number: 2343313 Country of ref document: CA Kind code of ref document: A Ref document number: 2000 570203 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020017003306 Country of ref document: KR Ref document number: PA/a/2001/002674 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 55047/99 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 511031 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999941420 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09787032 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1999941420 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1020017003306 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 55047/99 Country of ref document: AU |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999941420 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: 1020017003306 Country of ref document: KR |